The immune system is designed to protect us by keeping abnormal cells in check. But one way that cancer cells proliferate is by ‘hijacking’ or manipulating the immune system, allowing tumours to evade the immune processes. To overcome this immune evasion, we are developing bispecific antibodies, which simultaneously target two proteins to generate a stronger response against cancer, and potentially offering the benefits of two medicines in one.
Learn more about how we are leading a revolution in oncology to define cancer care: www.astrazeneca.com/our-thera...
------------------------------------------------------------
Global site: www.astrazeneca.com/
Careers site: careers.astrazeneca.com/
Follow us:
Twitter: / astrazeneca
LinkedIn: / astrazeneca
Instagram: / astrazeneca
Facebook: / astrazeneca
11 дек 2023
